Yahoo Web Search

Search results

  1. Jun 24, 2021 · Tony Cataldo, the CEO of GT Biopharma, a clinical stage immuno-oncology company, will speak at the Global Family Office Investment Summit in Monaco in June 2021. GT Biopharma develops TriKE™ protein biologic products for cancer treatment.

  2. Tony Cataldo came on the Investment Spotlight Series to speak with Chris Versace and Jay Coulter about GT Biopharma's outlook. Tony's Biography (From Their Website) Mr. Cataldo founded GT ...

    • 52 min
    • 3.1K
    • Financial Advisor TV™
  3. Patrick Tsang interviews Anthony Cataldo, the CEO of GT Biopharma, a clinical-stage immuno-oncology company developing innovative therapies based on proprietary NK cell engager (TriKE®)...

    • 16 min
    • 20.9K
    • Anything is Possible Podcast with Patrick Tsang
  4. Dec 21, 2021 · On December 15, 2021, Anthony Cataldo resigned as a member of the GT Biopharma, Inc.’s board of directors.

  5. Jun 24, 2021 · Tony Cataldo, the CEO of GT Biopharma, a clinical stage immuno-oncology company, will speak at the Global Family Office Investment Summit in Monaco in June 2021. GT Biopharma develops TriKE™, a protein biologic technology platform that enhances natural killer cells' cancer killing abilities.

  6. Alan Urban has over 30 years of corporate finance and accounting experience for a variety of public and private companies. Most notably Mr. Urban served as a member of the board of directors of GT Biopharma, Inc. (NASDAQ: GTBP), from mid-2022 to mid-2023; and as Chief Financial Officer for Research Solutions, Inc. (NASDAQ: RSSS), a SaaS and ...

  7. People also ask

  8. Aug 13, 2021 · GT Biopharma, Inc. ( NASDAQ: GTBP) Q2 2021 Earnings Conference Call August 13, 2021 8:30 AM ET. Company Participants. David Castaneda - Investor Relations. Tony Cataldo - Chairman & Chief ...